International Stem Cell CORP
ISCO- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001355790
In the last 90 days, International Stem Cell CORP insiders filed 0 open-market purchases and 1 sale; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding International Stem Cell CORP changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 1 | 1 | 0 |
| Shares | 20 | 20 | 0 (0.0%) |
| Value | $0 | $0 | $0 |
New holders (0)
Institutions that held International Stem Cell CORP at the end of Q2 2022 but not at the end of Q1 2022.
None.
Sold out (0)
Institutions that held International Stem Cell CORP at the end of Q1 2022 and filed for Q2 2022 without it.
None.